FDA Inspection 1048445 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on March 30, 2018 in New Hyde Park, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 30, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New Hyde Park, NY (United States)